Search Results - "Tomizawa, D."
-
1
Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in children
Published in Leukemia (01-03-2017)“…In the treatment of childhood acute lymphoblastic leukemia (ALL), excess shortening of maintenance therapy resulted in high relapse rate, as shown by our…”
Get full text
Journal Article -
2
High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML
Published in Leukemia (01-05-2015)“…EVI1 and MEL1 are homolog genes whose transcriptional activations by chromosomal translocations are known in small subsets of leukemia. From gene expression…”
Get full text
Journal Article -
3
Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children
Published in Leukemia (01-12-2013)Get full text
Journal Article -
4
Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
Published in Leukemia (01-12-2015)Get full text
Journal Article -
5
Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia
Published in Leukemia (01-02-2015)“…Sixty-two infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia (MLL-r ALL) were treated with the MLL03 protocol of the Japanese Pediatric…”
Get full text
Journal Article -
6
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects : a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group
Published in Leukemia (01-11-2007)“…We evaluated the efficacy of a treatment strategy in which infants with acute lymphoblastic leukemia (ALL) were stratified by their MLL gene status and then…”
Get full text
Journal Article -
7
Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999
Published in Leukemia (01-02-2010)“…We report the long-term results of Tokyo Children's Cancer Study Group's studies L84-11, L89-12, L92-13, and L95-14 for 1846 children with acute lymphoblastic…”
Get full text
Journal Article -
8
Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation
Published in Bone marrow transplantation (Basingstoke) (01-09-2014)“…Hematopoietic cell transplantation (HCT) is used for treatment of hematopoietic diseases. Assessment of T- and B-cell reconstitution after HCT is crucial…”
Get full text
Journal Article -
9
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
Published in Blood cancer journal (New York) (11-07-2014)“…CCAAT/enhancer-binding protein alpha ( CEBPA ) mutations are a favorable prognostic factor in adult acute myeloid leukemia (AML) patients; however, few studies…”
Get full text
Journal Article -
10
-
11
Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team
Published in Bone marrow transplantation (Basingstoke) (01-03-2006)“…We retrospectively analyzed our results of 30 patients with three distinctive primary immunodeficiency diseases (PIDs)--severe combined immunodeficiency (SCID,…”
Get full text
Journal Article -
12
Invasive Subglottal Aspergillosis in a Patient with Severe Aplastic Anemia: A Case Report
Published in The Journal of infection (01-04-2002)“…A 19-year-old female with aplastic anemia who developed subglottal aspergillosis is reported. She presented with fever, cough and stridor. Inspiratory dyspnea…”
Get full text
Journal Article -
13
High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factor
Published in Pediatric blood & cancer (01-02-2024)“…CD25 is an aberrant marker expressed on the leukemic stem cell (LSC) surface and an immunotherapy target in acute myeloid leukemia (AML). However, the clinical…”
Get full text
Journal Article -
14
MULTI-OMICS ANALYSIS DISSECTS M-MDSC LIKE IMMUNOMODULATORY CHARACTERISTICS OF LINEAGE SWITCHED AML WITH KMT2A-AFF1
Published in PEDIATRIC BLOOD & CANCER (2024)Get full text
Conference Proceeding -
15
Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms
Published in Blood (20-06-2024)“…•This study provides an overall picture of driver mutations in ML-DS, including novel and frequent IRX1 and ZBTB7A mutations, and RUNX1-PTD.•CDKN2A and TP53…”
Get full text
Journal Article -
16
Prognosis of Pediatric Acute Myeloid Leukemia with KMT2A-MLLT3 According to DNA Methylation Patterns: Jccg JPLSG AML-05 Study
Published in BLOOD (15-11-2022)Get full text
Journal Article Conference Proceeding -
17
UBTF‐internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia
Published in Genes chromosomes & cancer (01-04-2023)“…The prognosis of pediatric acute myeloid leukemia (AML) has improved via stratification therapy. However, relapse or death occurs in 30%–40% of cases. Novel…”
Get full text
Journal Article -
18
Risk-stratified therapy for infant ALL
Published in Blood (15-10-2020)Get full text
Journal Article -
19
TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia
Published in Genes chromosomes & cancer (01-07-2023)“…Pediatric acute myeloid leukemia (AML) is a poor prognostic subtype of pediatric leukemia. However, the detailed characteristics of many genetic abnormalities…”
Get full text
Journal Article -
20
RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis
Published in Blood (17-05-2018)Get full text
Journal Article